
EquityEquity - OtherVery High Risk
Direct
NAV (11-Dec-25)
Returns (Since Inception)
Fund Size
₹2,118 Cr
Expense Ratio
0.58%
ISIN
INF174KA1TG9
Minimum SIP
₹100
Exit Load
No Charges
Inception Date
28 Oct 2024
In this section, we compare the returns of the scheme with the category average over various periods. Periods for which the fund has outperformed its category average are marked in green, otherwise red.
1 Year
+3.60%
— (Cat Avg.)
Since Inception
+6.47%
— (Cat Avg.)
| Equity | ₹2,110.5 Cr | 99.65% |
| Others | ₹7.36 Cr | 0.35% |
All Holdings
Equity
Debt & Others
| Name | Type | Amount | Holdings |
|---|---|---|---|
| Maruti Suzuki India Ltd | Equity | ₹198.75 Cr | 9.38% |
| Britannia Industries Ltd | Equity | ₹154.22 Cr | 7.28% |
| Hindustan Unilever Ltd | Equity | ₹132.58 Cr | 6.26% |
| Nestle India Ltd | Equity | ₹82.73 Cr | 3.91% |
| Vedanta Ltd | Equity | ₹78.9 Cr | 3.73% |
| Acutaas Chemicals Ltd | Equity | ₹71.57 Cr | 3.38% |
| Ashok Leyland Ltd | Equity | ₹65.46 Cr | 3.09% |
| United Spirits Ltd | Equity | ₹63 Cr | 2.97% |
| J.B. Chemicals & Pharmaceuticals Ltd | Equity | ₹62.88 Cr | 2.97% |
| GE Vernova T&D India Ltd | Equity | ₹59.65 Cr | 2.82% |
| Azad Engineering Ltd | Equity | ₹57 Cr | 2.69% |
| Oracle Financial Services Software Ltd | Equity | ₹56.75 Cr | 2.68% |
| Nippon Life India Asset Management Ltd Ordinary Shares | Equity | ₹52.54 Cr | 2.48% |
| Cummins India Ltd | Equity | ₹50.08 Cr | 2.36% |
| Aster DM Healthcare Ltd Ordinary Shares | Equity | ₹48.25 Cr | 2.28% |
| Bharti Airtel Ltd | Equity | ₹46.24 Cr | 2.18% |
| Schaeffler India Ltd | Equity | ₹45.97 Cr | 2.17% |
| Swiggy Ltd | Equity | ₹45.4 Cr | 2.14% |
| MTAR Technologies Ltd | Equity | ₹44.27 Cr | 2.09% |
| ZF Commercial Vehicle Control Systems India Ltd | Equity | ₹43.09 Cr | 2.03% |
| Timken India Ltd | Equity | ₹42.08 Cr | 1.99% |
| Fortis Healthcare Ltd | Equity | ₹41.36 Cr | 1.95% |
| Siemens Ltd | Equity | ₹40.75 Cr | 1.92% |
| Jubilant Pharmova Ltd | Equity | ₹39.23 Cr | 1.85% |
| Marksans Pharma Ltd | Equity | ₹37.59 Cr | 1.77% |
| Mphasis Ltd | Equity | ₹36.55 Cr | 1.73% |
| Bosch Ltd | Equity | ₹33.64 Cr | 1.59% |
| Siemens Energy India Ltd | Equity | ₹31.6 Cr | 1.49% |
| Midwest Ltd | Equity | ₹31.4 Cr | 1.48% |
| Tega Industries Ltd | Equity | ₹31.19 Cr | 1.47% |
| ABB India Ltd | Equity | ₹31.05 Cr | 1.47% |
| LG Electronics India Ltd | Equity | ₹30.08 Cr | 1.42% |
| Glenmark Pharmaceuticals Ltd | Equity | ₹29.19 Cr | 1.38% |
| Grindwell Norton Ltd | Equity | ₹28.37 Cr | 1.34% |
| Gland Pharma Ltd | Equity | ₹28.15 Cr | 1.33% |
| Tata Chemicals Ltd | Equity | ₹26.01 Cr | 1.23% |
| Hyundai Motor India Ltd | Equity | ₹23.26 Cr | 1.10% |
| Anthem Biosciences Ltd | Equity | ₹19.99 Cr | 0.94% |
| KSB Ltd | Equity | ₹18.66 Cr | 0.88% |
| CRISIL Ltd | Equity | ₹18.18 Cr | 0.86% |
| Samvardhana Motherson International Ltd | Equity | ₹17.45 Cr | 0.82% |
| Triparty Repo | Cash - Repurchase Agreement | ₹17.2 Cr | 0.81% |
| Orchid Pharma Ltd | Equity | ₹15.43 Cr | 0.73% |
| Net Current Assets/(Liabilities) | Cash | ₹-9.84 Cr | 0.46% |
Large Cap Stocks
42.52%
Mid Cap Stocks
25.25%
Small Cap Stocks
28.04%
Equity Sector
Debt & Others
| Sector | Amount | Holdings |
|---|---|---|
| Industrials | ₹468.54 Cr | 22.12% |
| Consumer Defensive | ₹432.52 Cr | 20.42% |
| Consumer Cyclical | ₹407.56 Cr | 19.24% |
| Healthcare | ₹322.08 Cr | 15.21% |
| Basic Materials | ₹207.88 Cr | 9.82% |
| Technology | ₹123.37 Cr | 5.83% |
| Financial Services | ₹70.72 Cr | 3.34% |
| Communication Services | ₹46.24 Cr | 2.18% |
| Utilities | ₹31.6 Cr | 1.49% |
Standard Deviation
This fund
--
Cat. avg.
--
Lower the better
Sharpe Ratio
This fund
--
Cat. avg.
--
Higher the better
Sortino Ratio
This fund
--
Cat. avg.
--
Higher the better
Since October 2024

Since October 2024
Since October 2024
ISIN INF174KA1TG9 | Expense Ratio 0.58% | Exit Load No Charges | Fund Size ₹2,118 Cr | Age 1 year 1 month | Lumpsum Minimum ₹100 | Fund Status Open Ended Investment Company | Benchmark Nifty MNC TR INR |
To seek to generate long-term capital growth from an actively managed portfolio primarily of Equity and Equity Related Securities. Scheme shall invest in Indian equities,foreign equities and related instruments and debt securities.
Note: As per the Income Tax Budget 2024, mutual funds are subject to capital gains taxation, which includes surcharge and cess based on prevailing income tax rules and the investor’s income. Taxation applies only to realised gains, not notional gains. Please consult your tax advisors to determine the implications or consequences of your investments in such securities.

Total AUM
₹5,83,270 Cr
Address
2nd Floor, 12-BKC, Plot No C-12, Mumbai, 400 051
Your principal amount will be at Very High Risk


EquityEquity - OtherVery High Risk
Direct
NAV (11-Dec-25)
Returns (Since Inception)
Fund Size
₹2,118 Cr
Expense Ratio
0.58%
ISIN
INF174KA1TG9
Minimum SIP
₹100
Exit Load
No Charges
Inception Date
28 Oct 2024
Your principal amount will be at Very High Risk

In this section, we compare the returns of the scheme with the category average over various periods. Periods for which the fund has outperformed its category average are marked in green, otherwise red.
1 Year
+3.60%
— (Cat Avg.)
Since Inception
+6.47%
— (Cat Avg.)
| Equity | ₹2,110.5 Cr | 99.65% |
| Others | ₹7.36 Cr | 0.35% |
All Holdings
Equity
Debt & Others
| Name | Type | Amount | Holdings |
|---|---|---|---|
| Maruti Suzuki India Ltd | Equity | ₹198.75 Cr | 9.38% |
| Britannia Industries Ltd | Equity | ₹154.22 Cr | 7.28% |
| Hindustan Unilever Ltd | Equity | ₹132.58 Cr | 6.26% |
| Nestle India Ltd | Equity | ₹82.73 Cr | 3.91% |
| Vedanta Ltd | Equity | ₹78.9 Cr | 3.73% |
| Acutaas Chemicals Ltd | Equity | ₹71.57 Cr | 3.38% |
| Ashok Leyland Ltd | Equity | ₹65.46 Cr | 3.09% |
| United Spirits Ltd | Equity | ₹63 Cr | 2.97% |
| J.B. Chemicals & Pharmaceuticals Ltd | Equity | ₹62.88 Cr | 2.97% |
| GE Vernova T&D India Ltd | Equity | ₹59.65 Cr | 2.82% |
| Azad Engineering Ltd | Equity | ₹57 Cr | 2.69% |
| Oracle Financial Services Software Ltd | Equity | ₹56.75 Cr | 2.68% |
| Nippon Life India Asset Management Ltd Ordinary Shares | Equity | ₹52.54 Cr | 2.48% |
| Cummins India Ltd | Equity | ₹50.08 Cr | 2.36% |
| Aster DM Healthcare Ltd Ordinary Shares | Equity | ₹48.25 Cr | 2.28% |
| Bharti Airtel Ltd | Equity | ₹46.24 Cr | 2.18% |
| Schaeffler India Ltd | Equity | ₹45.97 Cr | 2.17% |
| Swiggy Ltd | Equity | ₹45.4 Cr | 2.14% |
| MTAR Technologies Ltd | Equity | ₹44.27 Cr | 2.09% |
| ZF Commercial Vehicle Control Systems India Ltd | Equity | ₹43.09 Cr | 2.03% |
| Timken India Ltd | Equity | ₹42.08 Cr | 1.99% |
| Fortis Healthcare Ltd | Equity | ₹41.36 Cr | 1.95% |
| Siemens Ltd | Equity | ₹40.75 Cr | 1.92% |
| Jubilant Pharmova Ltd | Equity | ₹39.23 Cr | 1.85% |
| Marksans Pharma Ltd | Equity | ₹37.59 Cr | 1.77% |
| Mphasis Ltd | Equity | ₹36.55 Cr | 1.73% |
| Bosch Ltd | Equity | ₹33.64 Cr | 1.59% |
| Siemens Energy India Ltd | Equity | ₹31.6 Cr | 1.49% |
| Midwest Ltd | Equity | ₹31.4 Cr | 1.48% |
| Tega Industries Ltd | Equity | ₹31.19 Cr | 1.47% |
| ABB India Ltd | Equity | ₹31.05 Cr | 1.47% |
| LG Electronics India Ltd | Equity | ₹30.08 Cr | 1.42% |
| Glenmark Pharmaceuticals Ltd | Equity | ₹29.19 Cr | 1.38% |
| Grindwell Norton Ltd | Equity | ₹28.37 Cr | 1.34% |
| Gland Pharma Ltd | Equity | ₹28.15 Cr | 1.33% |
| Tata Chemicals Ltd | Equity | ₹26.01 Cr | 1.23% |
| Hyundai Motor India Ltd | Equity | ₹23.26 Cr | 1.10% |
| Anthem Biosciences Ltd | Equity | ₹19.99 Cr | 0.94% |
| KSB Ltd | Equity | ₹18.66 Cr | 0.88% |
| CRISIL Ltd | Equity | ₹18.18 Cr | 0.86% |
| Samvardhana Motherson International Ltd | Equity | ₹17.45 Cr | 0.82% |
| Triparty Repo | Cash - Repurchase Agreement | ₹17.2 Cr | 0.81% |
| Orchid Pharma Ltd | Equity | ₹15.43 Cr | 0.73% |
| Net Current Assets/(Liabilities) | Cash | ₹-9.84 Cr | 0.46% |
Large Cap Stocks
42.52%
Mid Cap Stocks
25.25%
Small Cap Stocks
28.04%
Equity Sector
Debt & Others
| Sector | Amount | Holdings |
|---|---|---|
| Industrials | ₹468.54 Cr | 22.12% |
| Consumer Defensive | ₹432.52 Cr | 20.42% |
| Consumer Cyclical | ₹407.56 Cr | 19.24% |
| Healthcare | ₹322.08 Cr | 15.21% |
| Basic Materials | ₹207.88 Cr | 9.82% |
| Technology | ₹123.37 Cr | 5.83% |
| Financial Services | ₹70.72 Cr | 3.34% |
| Communication Services | ₹46.24 Cr | 2.18% |
| Utilities | ₹31.6 Cr | 1.49% |
Standard Deviation
This fund
--
Cat. avg.
--
Lower the better
Sharpe Ratio
This fund
--
Cat. avg.
--
Higher the better
Sortino Ratio
This fund
--
Cat. avg.
--
Higher the better
Since October 2024

Since October 2024
Since October 2024
ISIN INF174KA1TG9 | Expense Ratio 0.58% | Exit Load No Charges | Fund Size ₹2,118 Cr | Age 1 year 1 month | Lumpsum Minimum ₹100 | Fund Status Open Ended Investment Company | Benchmark Nifty MNC TR INR |
To seek to generate long-term capital growth from an actively managed portfolio primarily of Equity and Equity Related Securities. Scheme shall invest in Indian equities,foreign equities and related instruments and debt securities.
Note: As per the Income Tax Budget 2024, mutual funds are subject to capital gains taxation, which includes surcharge and cess based on prevailing income tax rules and the investor’s income. Taxation applies only to realised gains, not notional gains. Please consult your tax advisors to determine the implications or consequences of your investments in such securities.

Total AUM
₹5,83,270 Cr
Address
2nd Floor, 12-BKC, Plot No C-12, Mumbai, 400 051
Get your portfolio reviewed by experts
Download Wealth Monitor App
Track and monitor all
your investments